Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
160,529,963
-
Total 13F shares
-
9,025,367
-
Share change
-
+9,024,894
-
Total reported value
-
$126,411,175
-
Price per share
-
$14.24
-
Number of holders
-
42
-
Value change
-
+$126,404,075
-
Number of buys
-
41
Institutional Holders of Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) as of Q3 2018
As of 30 Sep 2018,
Gritstone bio, Inc. - Common Stock, $0.0001 par value per share (GRTS) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,025,367 shares.
The largest 10 holders included
Redmile Group, LLC, FMR LLC, Partner Fund Management, L.P., Alphabet Inc., Casdin Capital, LLC, GOLDMAN SACHS GROUP INC, Artal Group S.A., Wildcat Capital Management, LLC, Foresite Capital Management IV, LLC, and JPMORGAN CHASE & CO.
This page lists
42
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.